How Neuroleptic Malignant Syndrome Medications Work

Neuroleptic Malignant Syndrome (NMS) is a rare but life-threatening condition associated with the use of antipsychotic medications. It is characterized by high fever, muscle rigidity, autonomic dysfunction, altered mental status, and tachycardia.

Treatment Options

• Bromocriptine (Gold Standard): A dopamine agonist that has been shown to be effective in treating NMS. It works by stimulating dopamine receptors in the brain, which helps to reduce muscle rigidity and fever.
• Alternatives:
  • Dantrolene: A direct-acting skeletal muscle relaxant that can help to reduce muscle rigidity and fever.
  • Molindone: An antipsychotic medication that has been used off-label to treat NMS, although its effectiveness is not well established.
  • Risperidone: Another antipsychotic medication that may be used in some cases of NMS, but it should be used with caution due to the risk of exacerbating the condition.

Pathophysiology and Risk Factors

NMS is thought to occur when antipsychotic medications block dopamine receptors in the brain, leading to an imbalance between dopamine and other neurotransmitters. This can cause a range of symptoms, including high fever, muscle rigidity, and autonomic dysfunction.

The risk factors for NMS include long-term use of antipsychotic medications, history of previous NMS episodes, age > 40 years, and dehydration or electrolyte imbalance. Early recognition and treatment are critical to preventing serious complications and improving outcomes.